Susquehanna Fundamental Investments, LLC Precigen, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $217,754 - $430,876	-154,436 Reduced 79.69%	39,355 $83,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $240,050 - $374,016	68,003 Added 54.06%	193,791 $719,000
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $56,741 - $74,480	11,371 Added 9.94%	125,788 $628,000
Q2 2021 Aug 11, 2021	SELL	$6.24 - $8.22 $273,199 - $359,888	-43,782 Reduced 27.68%	114,417 $746,000
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $31,500 - $88,704	8,400 Added 5.61%	158,199 $1.61 Million
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $108,150 - $191,580	30,900 Added 25.99%	149,799 $524,000
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $256,821 - $649,188	118,899 New	118,899 $593,000

141

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $231M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.